Novartis Institutes for BioMedical Research Inc. 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-31 4:05 pm Unchanged |
2022-08-08 | 13G | Pliant Therapeutics, Inc. PLRX |
Novartis Institutes for BioMedical Research Inc. | 2,153,526 4.400% |
0 (Unchanged) |
Filing |
| 2020-06-15 4:40 pm Purchase |
2020-06-05 | 13G | Pliant Therapeutics, Inc. PLRX |
Novartis Institutes for BioMedical Research Inc. | 2,153,526 6.100% |
2,153,526 (New Position) |
Filing |